Non Alcoholic Squash Market

Non-Alcoholic Squash Market Segmentation By nature (Organic and Conventional); By fruit type (berries, citrus fruits, tropical fruits, pomes and drupes); By end-use (HoReCa and Retail); By Packaging (Glass, Plastics, Can and Beverage Cartoons); By Distribution (Direct Sales and Indirect Sales-Hypermarket/ Supermarket, Convenience and Departmental Stores, Specialty Stores and Online Retail) - Global Demand Analysis & Opportunity Outlook 2027

Buy Now
Report ID: 1218 | Published On: Feb 06, 2023
  1. Introduction
    • Market Definition
    • Market Segmentation
    • Product Overview
  2. Assumptions and Acronyms
  3. Research Methodology
  4. Research Process
    • Primary Research
    • Manufacturers
    • Distributors
    • End Users
    • Secondary Research
    • Market Size Estimation
  5. Executive Summary - Global Advanced Therapy Medicinal Products Market
  6. Analysis of Market Dynamics
  7. Drivers
  8. Trends
  9. Key Market Opportunities for Business Growth
  10. Major Roadblocks for the Market Growth
  11. Regulatory & Standard Landscape
  12. Value Chain Analysis
  13. Potential ATMP Treatment Analysis
  14. Pricing Analysis of Global Advanced Therapy Medicinal Products Market
  15. Use Case Analysis
  16. Pipeline Analysis
  17. Analysis on the Manufacturing Process
  18. Analysis of COVID-19 Impact on the Global Advanced Therapy Medicinal Products Market
  19. Analysis of End-User Market Share of Global Advanced Therapy Medicinal Products
  20. Competitive Positioning
  21. Competitive Landscape
  22. Market Share Analysis of Major Players (%), 2021
  23. Competitive Benchmarking
  24. Novartis AG.
  25. Takeda Pharmaceutical Company Limited
  26. Gilead Sciences, Inc.
  27. Bluebird Bio, Inc
  28. BioMarin Pharmaceutical Inc
  29. Vericel Corporation
  30. Mallinckrodt Pharmaceuticals
  31. UniQure N.V.
  32. JCR Pharmaceuticals Co., Ltd.
  33. Spark Therapeutics, Inc. (Parent Company: Roche)
  34. Kolon TissueGene, Inc.
  35. Global Advanced Therapy Medicinal Products Market Outlook
  36. By Value (USD million)
  37. By Product
  38. CAR-T Therapy, 2021-2031F (USD million)
  39. Gene Therapy, 2021-2031F (USD million)
  40. Cell Therapy, 2021-2031F (USD million)
  41. Tissue Engineered Product, 2021-2031F (USD million)
  42. By Disease
  43. Oncology, 2021-2031F (USD million)
  44. Genetic Disorders, 2021-2031F (USD million)
  45. CNS, 2021-2031F (USD million)
  46. Dermatology, 2021-2031F (USD million)
  47. Others, 2021-2031F (USD million)
  48. By End-User
  49. Hospitals & Clinics, 2021-2031F (USD million)
  50. Research & Academic Institutes, 2021-2031F (USD million)
  51. Global Advanced Therapy Medicinal Products Market by Region
  52. North America, 2021-2031F (USD million)
  53. Europe, 2021-2031F (USD million)
  54. Asia-Pacific, 2021-2031F (USD million)
  55. Latin America, 2021-2031F (USD million)
  56. Middle East & Africa, 2021-2031F (USD million)
  57. North America Advanced Therapy Medicinal Products Market Outlook
  58. By Value (USD million)
  59. By Product
  60. CAR-T Therapy, 2021-2031F (USD million
  61. Gene Therapy, 2021-2031F (USD million)
  62. Cell Therapy, 2021-2031F (USD million)
  63. Tissue Engineered Product, 2021-2031F (USD million)
  64. By Disease
  65. Oncology, 2021-2031F (USD million)
  66. Genetic Disorders, 2021-2031F (USD million)
  67. CNS, 2021-2031F (USD million)
  68. Dermatology, 2021-2031F (USD million)
  69. Others, 2021-2031F (USD million)
  70. By End-User
  71. Hospitals & Clinics, 2021-2031F (USD million)
  72. Research & Academic Institutes, 2021-2031F (USD million)
  73. By Country
  74. US, 2021-2031F (USD million)
  75. Canada, 2021-2031F (USD million)
  76. Europe Advanced Therapy Medicinal Products Market Outlook
  77. By Product
  78. By Disease
  79. By End User
  80. By Country
  81. UK, 2021-2031F (USD Million)
  82. Germany, 2021-2031F (USD Million)
  83. France, 2021-2031F (USD Million)
  84. Italy, 2021-2031F (USD Million)
  85. Spain, 2021-2031F (USD Million)
  86. Russia, 2021-2031F (USD Million)
  87. Netherlands, 2021-2031F (USD Million)
  88. Rest of Europe, 2021-2031F (USD Million)
  89. Asia Pacific Advanced Therapy Medicinal Products Market Outlook
  90. By Product
  91. By Disease
  92. By End User
  93. By Country
  94. China, 2021-2031F (USD Million)
  95. India, 2021-2031F (USD Million)
  96. Japan, 2021-2031F (USD Million)
  97. South Korea, 2021-2031F (USD Million)
  98. Singapore, 2021-2031F (USD Million)
  99. Australia, 2021-2031F (USD Million)
  100. Rest of Asia-Pacific, 2021-2031F (USD Million)
  101. Latin America Advanced Therapy Medicinal Products Market Outlook
  102. By Product
  103. By Disease
  104. By End User
  105. By Country
  106. Brazil, 2021-2031F (USD Million)
  107. Argentina, 2021-2031F (USD Million)
  108. Mexico, 2021-2031F (USD Million)
  109. Rest of Latin America, 2021-2031F (USD Million)
  110. Middle East & Africa Advanced Therapy Medicinal Products Market Outlook
  111. By Product
  112. By Disease
  113. By End User
  114. By Country
  115. GCC, 2021-2031F (USD Million)
  116. Israel, 2021-2031F (USD Million)
  117. South Africa, 2021-2031F (USD Million)
  118. Rest of Middle East & Africa, 2021-2031F (USD Million)

Preview Analysis

Request Insights
Inflation and Looming Recession to Haunt Businesses:

In 2023, market players might incur losses due to huge gap in currency translation followed by contracting revenues, shrinking profit margins & cost pressure on logistics and supply chain.
Controlling Inflation has become the first priority for global economies from last quarter of 2022 and to be followed in 2023. With skewed economic situations, rise in interest rate by governments to control spending and inflation, spiked oil and gas prices, high inflation, geo-political issues including U.S. & China trade war, Russia-Ukraine conflict to intensify the global economic issues.
The interest rates in the U.S. may be less sensitive in 2023 as compared to 2022; sigh of relief for businesses. Positive business sentiments, healthy business balance sheets, growth in construction spending (private construction value in 2022 stood at $1,429.2 billion, 11.7 percent (±1.0 percent) above the $1,279.5 billion spent in 2021, Residential construction in 2022 was $899.1 billion, up by 13.3 percent (±2.1 percent) from $793.7 billion in 2021, non-residential construction touched $530.1 billion, 9.1 percent (±1.0 percent) above the $485.8 billion in 2021.) showcases minimal impact of recession in the country.
Similarly, spiked spending in the European and major Asia economics including, India, China & Japan to showcase less impact on the global demand.

In The News

Product Overview

Non-alcoholic squash is concentrated syrup that is made up of fruit ingredients. They are generally non-alcoholic in nature and not fermented. Presently, various companies’ offers sugar free squash. Ginger extract and herbal extract are also added to enhance the quality of squash. Cocktails are generally made by mixing squash with alcoholic drinks. Non-alcoholic squash has good shelf life with added preservatives. Squash contains natural ingredients that are rich in vitamins and are considered healthy in comparison to aerated drinks which directly boost the non-alcoholic squash market.

Market Size and Forecast

The CAGR of Non-Alcoholic squash market expected to be around 6.7% during 2018-2027.It is expected to reach USD 29.5 Billion by the year 2027.Global non-alcoholic squash market was valued at USD 19.1 Billion by the year 2019.The demand for non-alcoholic squash is expected to show robust growth during the forecast period owing to the increasing consumer preference for the healthy drinks in comparison to carbonated drinks.

The global nonalcoholic squash market is segmented on the basis of nature, fruit type, end-use, packaging and distribution. In fruit type segment citrus fruits segment is anticipated to grow at faster rate owing to the high availability of fruit in different regions.

By region, the global non-alcoholic squash market is segmented into North America, Latin America, Europe, Asia-Pacific, Middle East and Africa. Asia pacific region is anticipated witness the highest growth in global non-alcoholic squash market. In Asia Pacific region, China and India are the major countries that contribute maximum market share owing to burgeoning population and large numbers of players operating in the non-alcoholic squash market.

Europe is the second largest region in the non-alcoholic squash market with significant consumption rate. Countries such as Spain, Italy, U.K. and Germany constitutes significant market share in the region owing to the growing popularity of non-carbonated in the region. 


Market Segments

Our in-depth analysis segmented the Global non-alcoholic squash market in the following segments:

By Nature

  • Organic
  • Conventional

By Fruit Type

  • Berries
  • Citrus fruits
  • Tropical fruits
  • Pomes
  • Drupes

By End-Use

  • HoReCa(Hotels/Restaurants/Cafe)
  • Retail

By Packaging

  • Glass
  • Plastics
  • Can
  • Beverage cartoons

By Distribution

  • Direct Sales
  • Indirect Sales
    • Hypermarket/ supermarket
    • Convenience and
    • Departmental stores
    • Specialty stores
    • Online retail

By Region

Global non-alcoholic squash market is further classified on the basis of region as follows:

  • North America (United States, Canada), Market size, Y-O-Y growth Market size, Y-O-Y growth & Opportunity Analysis, Future forecast & Opportunity Analysis
  • Latin America (Brazil, Mexico, Argentina, Rest of LATAM), Market size, Y-O-Y growth, Future forecast & Opportunity Analysis
  • Europe (U.K., Germany, France, Italy, Spain, Hungary, BENELUX (Belgium, Netherlands, Luxembourg), NORDIC (Norway, Denmark, Sweden, Finland), Poland, Russia, Rest of Europe), Market size, Y-O-Y growth, Future forecast & Opportunity Analysis
  • Asia-Pacific (China, India, Japan, South Korea, Malaysia, Indonesia, Taiwan, Hong Kong, Australia, New Zealand, Rest of Asia-Pacific), Market size, Y-O-Y growth, Future forecast & Opportunity Analysis
  • Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa), Market size, Y-O-Y growth, Future forecast & Opportunity Analysis

Get more information on this report: Request Sample PDF

Market Drivers

The increasing health consciousness among the consumers coupled with increasing preference among consumers for beverages that have higher nutritional content such as vitamins and minerals is driving the market growth over the forecast period. Additionally, increasing demand of organic non-alcoholic squash due to various health benefits is also expected to promote the market growth. Moreover, growing demand for sugar free drinks that doesn’t include artificial color is expected to drive the global non-alcoholic Squash market. The squash consists of functional ingredients such as vitamin which is another reason for the growth of squash market. The product launches, merger and acquisitions are some of the key business strategies which are adopted by players for the expansion of non-alcoholic squash market.

The major restraining factor is the presence of fructose in the non-alcoholic squash drinks which can cause health issues such as diabetes and obesity.

Get more information on this report: Request Sample PDF

Top Featured Companies Dominating The Market

    • Pepsico inc.,
    • Evergreen juices inc.,
    • Dabur
    • Parle agro
    • The Coca-Cola company
    • James white drinks
    • Evolution fresh, suja life, llc
    • Höllinger
    • Nectar imports ltd.,
    • Anpellegrino s.p.a
    • Robinsons
    • Kissan
    • Britvic
    • Hamdard
    • Assis
    • Prigat
    • Primor
    • Suntory
    • Nichols
    • Sunquick 

Let Us Hear About Your Requirements:

Submit Your Request For Proposal (RFP)

Submit RFP    Buy Now Download Research Report Sample